ArticleCancer cellPublished
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
12 of 31 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Cancer cell
- Published
- Topic
- Disease research
- Subject terms
- Humans; Breast Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Neoadjuvant Therapy; Biology; Female; Triple Negative Breast Neoplasms; Circulating Tumor DNA; Clinical Relevance; Erb-b2 Receptor Tyrosine Kinases; receptor subtype; Neoadjuvant chemotherapy
- PubMed ID
- 37146605
- PubMed Central ID
- PMC10330514
- Open access
- Yes, open
- Added to directory
- Source checked